- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.
Shares of the medical-device giant were climbing after unveiling strong earnings.